[HTML][HTML] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
…, P Tober-Lau, D Hillus, P Schommers, C Lehmann… - Nature medicine, 2022 - nature.com
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the
globe. This new variant of concern carries an unusually high number of mutations in key …
globe. This new variant of concern carries an unusually high number of mutations in key …
[HTML][HTML] Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
…, M Hallek, F Klein, I Suárez, C Lehmann - The Lancet Regional …, 2021 - thelancet.com
Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …
acute and the majority of patients fully recover, a significant fraction of patients now …
[HTML][HTML] Swarm learning for decentralized and confidential clinical machine learning
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new data, to …
recommendations to guide optimal practice. Objective Based on a critical evaluation of new data, to …
[HTML][HTML] Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy …
…, A Jessen, S Ruzicic, T Kümmerle, C Lehmann… - The Lancet, 2019 - thelancet.com
Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
…, M Witmer-Pack, M Platten, C Lehmann… - Nature, 2015 - nature.com
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was
largely ineffective in pre-clinical and clinical settings and was therefore abandoned 1 , 2 , 3 . …
largely ineffective in pre-clinical and clinical settings and was therefore abandoned 1 , 2 , 3 . …
Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial
D Taubert, R Roesen, C Lehmann, N Jung, E Schömig - Jama, 2007 - jamanetwork.com
ContextRegular intake of cocoa-containing foods is linked to lower cardiovascular mortality
in observational studies. Short-term interventions of at most 2 weeks indicate that high doses …
in observational studies. Short-term interventions of at most 2 weeks indicate that high doses …
[HTML][HTML] HIV-1 integration landscape during latent and active infection
…, BH Hahn, JL Czartoski, MJ McElrath, C Lehmann… - Cell, 2015 - cell.com
The barrier to curing HIV-1 is thought to reside primarily in CD4 + T cells containing silent
proviruses. To characterize these latently infected cells, we studied the integration profile of HIV…
proviruses. To characterize these latently infected cells, we studied the integration profile of HIV…
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Individuals infected with HIV-1 require lifelong antiretroviral therapy, because interruption of
treatment leads to rapid rebound viraemia. Here we report on a phase 1b clinical trial in …
treatment leads to rapid rebound viraemia. Here we report on a phase 1b clinical trial in …
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
…, TY Oliveira, GH Learn, YZ Cohen, C Lehmann… - Nature medicine, 2017 - nature.com
Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env)
protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here …
protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here …